BIOINF OÜ
Date of report 15.07.2026
Open the reports you want to print
Employees and salaries
BIOINF OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2026 II | ...... | ...... | ...... | ...... |
| 2026 I | ...... | ...... | ...... | ...... |
| 2025 IV | ...... | ...... | ...... | ...... |
| 2025 III | ...... | ...... | ...... | ...... |
| 2025 II | ...... | ...... | ...... | ...... |
| 2025 I | ...... | ...... | ...... | ...... |
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
| 2019 IV | ...... | ...... | ...... | ...... |
| 2019 III | ...... | ...... | ...... | ...... |
| 2019 II | ...... | ...... | ...... | ...... |
| 2019 I | ...... | ...... | ...... | ...... |
| 2018 IV | ...... | ...... | ...... | ...... |
| 2018 III | ...... | ...... | ...... | ...... |
| 2018 II | ...... | ...... | ...... | ...... |
| 2018 I | ...... | ...... | ...... | ...... |
| 2017 IV | ...... | ...... | ...... | ...... |
| 2017 III | ...... | ...... | ...... | ...... |
| 2017 II | ...... | ...... | ...... | ...... |
| 2017 I | ...... | ...... | ...... | ...... |
| 2016 IV | ...... | ...... | ...... | ...... |
| 2016 III | ...... | ...... | ...... | ...... |
| 2016 II | ...... | ...... | ...... | ...... |
| 2016 I | ...... | ...... | ...... | ...... |
| 2015 IV | ...... | ...... | ...... | ...... |
| 2015 III | ...... | ...... | ...... | ...... |
| 2015 II | ...... | ...... | ...... | ...... |
| 2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
BIOINF OÜ
Decision-makers?
Toomas Neuman
★★★★
......
Credit Score: ...
Reputation score: ...
Date of birth: ......
Active relations 3
*Every member of the management board may represent the private limited company in concluding all transactions.
BIOINF OÜ
History of right of representation?
Field
Administrative Activities
Business age
19y
Beneficial country:
Estonia
Toomas Neuman
... - ...
2007
2010
2012
2015
2018
2021
2023
2026
2007
2009
2010
2012
2014
2016
2017
2019
2021
2023
2024
2026
BIOINF OÜ
Owners?
Former owners
BIOINF OÜ
Other related parties?
Former other persons
| Name | Credit Score | Part | Beginning |
|---|---|---|---|
| ...... | ...... |
BIOINF OÜ
Subsidiaries and associates?
Former subsidiaries and associates
Former subsidiaries and associates
| Name | Credit Score | Payment | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... | ||
| ...... | ...... | ...... |
Beneficiaries
Volumes and values of beneficiaries' assets
Finances and assets
BIOINF OÜ
GoodwillBIOINF OÜ
Taxes paid and estimated average salariesBIOINF OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2025 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2025 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2025 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2025 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2015 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
BIOINF OÜ
Sales revenue by business areaBIOINF OÜ
Sales revenue by countryBIOINF OÜ
Financial indicators and prognosisBIOINF OÜ
Financial raiting: "GOOD" (2026 prognosis)2026 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
BIOINF OÜ
Annual reports| Year | Period | Submitted | Report PDF |
|---|---|---|---|
| 2024 | 01.01.2024–31.12.2024 | 03.07.2025 | ...... |
| 2023 | 01.01.2023–31.12.2023 | 09.12.2024 | ...... |
| 2022 | 01.01.2022–31.12.2022 | 05.12.2024 | ...... |
| 2021 | 01.01.2021–31.12.2021 | 09.09.2022 | ...... |
| 2020 | 01.01.2020–31.12.2020 | 28.06.2021 | ...... |
| 2019 | 01.01.2019–31.12.2019 | 27.10.2020 | ...... |
| 2018 | 01.01.2018–31.12.2018 | 26.06.2019 | ...... |
| 2017 | 01.01.2017–31.12.2017 | 02.07.2018 | ...... |
| 2016 | 01.01.2016–31.12.2016 | 30.06.2017 | ...... |
| 2015 | 01.01.2015–31.12.2015 | 28.06.2016 | ...... |
| 2014 | 01.01.2014–31.12.2014 | 27.06.2015 | ...... |
| 2013 | 01.01.2013–31.12.2013 | 30.06.2014 | ...... |
| 2012 | 01.01.2012–31.12.2012 | 13.06.2013 | ...... |
| 2011 | 01.01.2011–31.12.2011 | 29.06.2012 | ...... |
| 2010 | 01.01.2010–31.12.2010 | 28.06.2011 | ...... |
| 2009 | 01.01.2009–31.12.2009 | 29.06.2010 | ...... |
| 2008 | 01.01.2008–31.12.2008 | 17.06.2009 | ...... |
| 2007 | 01.01.2007–31.12.2007 | 06.06.2008 | ...... |
Liabilities and debts
BIOINF OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral
Borderline
Problematic
Risky
BIOINF OÜ
Reports and assets-liabilities overview 15.07.2026?
Annual reports:
......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
BIOINF OÜ
Claims history?
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
BIOINF OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2025 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2025 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2025 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2025 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 I | * ...... € | ...... € | ...... € | ...... € | ...... |
BIOINF OÜ
Bailiff's enforcement proceedings as of 15.07.2026?
| Claim duration | 792 days |
| Legal basis | y: TMS § 10 lg 2 TsMS § 317 lg 3 |
| Storage medium | Kohtutäitur Elin Vilippus |
| Principal claim | - |
| Secondary claim | - |
| State fee | - |
| TOTAL | - |
| Costs of proceedings | - |
Täitemenetluse teadeAvaldamise algus: 14.05.2024
Avaldamise lõpp: täitemenetluse lõppemiseni
Kohtutäitur Elin Vilippus avaldab teadaande täitemenetluse seadustiku (TMS) § 10 lõike 2 ja tsiviilkohtumenetluse seadustiku (TsMS) § 317 lõike 3 alusel.Kohtutäitur edastabxa0võlgnikule BIOINF OÜ (registrikood: 11359595) täitemenetlusega seotud teate. Sissenõudjaks on Osaühing EUROPARK ESTONIA (rk 10811490).Võlgnik BIOINF OÜ suhtes on algatatud täitemenetlus täiteasjas nr 022/2024/3513. Täitemenetluse algatamise aluseks on
Pärnu Maakohtu 03.05.2024 kohtumäärus tsiviilasjas nr 2-24-112377 ja sissenõudja Osaühing EUROPARK ESTONIA avaldus.Kohtutäitur on täitemenetluse läbiviimiseks teinud järgmised vajalikud kulutused:
1. Kohtutäituri büroo kulleriga dokumentide kättetoimetamise kulu 09.05.2024 summas 36,60 eurotTäitekulude väljamõistmise aluseks on täitemenetluse seadustiku (TMS) § 37 ja § 38. Võlgniku või sissenõudja nõudel peab kohtutäitur esitama täitekulude kohta dokumentaalseid tõendeid (alus: TMS § 39). Kohtutäitur Tallinna kohtutäitur Elin Vilippus, koostanud täitekulu arvestuse, otsustas mõista võlgnikult BIOINF OÜ välja täitekulu summas 36,60 eurot (sh käibemaks 6,60 eurot). Väljamõistetud täitekulu palume koheselt tasuda Tallinna kohtutäitur Elin Vilippus ametialasele arvelduskontole, märkides makse selgituseks '022/2024/3513, BIOINF OÜ'. Täitekulu tasumata jätmise korral on kohtutäituril õigus TMS § 2 lg 1 p 16 alusel pöörata täitekulu väljamõistmise otsus sundtäitmisele täitemenetluse seadustikus sätestatud korras.Kohtutäituri otsuse või tegevuse peale võib kohtutäiturile esitada kaebuse 10 päeva jooksul alates päevast, mil kaebaja sai teada või pidi teada saama otsuse või toimingu tegemisest. Kaebuse kohtutäituri tegevuse peale vaatab kohtutäitur läbi menetlusosaliste osavõtul 15 päeva jooksul ja teeb läbivaatamisest arvates 10 päeva jooksul otsuse. Kohtutäitur teatab menetlusosalistele kaebuse läbivaatamise aja. Menetlusosalise kaebuse läbivaatamisele ilmumata jäämine ei takista kaebuse läbivaatamist (alus: täitemenetluse seadustik § 217). Kaebuse kohta tehtud kohtutäituri otsuse peale võib menetlusosaline esitada otsuse kättetoimetamisest arvates kümne päeva jooksul kaebuse maakohtule, mille tööpiirkonnas kohtutäituri büroo asub. Kohtutäituri otsuse või tegevuse peale ilma eelnevalt kohtutäiturile kaebust esitamata kohtule kaevata ei saa (alus: täitemenetluse seadustik § 218).Täitekulu väljamõistmise otsus on kättesaadav Tallinna kohtutäitur Elin Vilippus büroos posti aadress: A.Lauteri 5, 10114 Tallinn. Akt loetakse kätte toimetatuks võlgnikule 15 päeva möödumisel väljaandes Ametlikud Teadaanded avaldamisest (alus: Täitemenetluse seadustik § 10 ja Tsiviilkohtumenetluse seadustik § 317).Menetluse nr: 022/2024/3513
Kohtutäitur Elin VilippusA. Lauteri 5, 10114 TallinnTelefon: 6840620E-post: elinvilippus.buroo@taitur.vilippus.ee
Teadaande number 2255955
BIOINF OÜ
Regulations of the Payment Order Department as of 15.07.2026?
Regulations of the Payment Order Department MISSING
BIOINF OÜ
Court orders in the register as of 15.07.2026?
Aruandetrahvimäärus
04.11.2024
Regulation number: Ä 10107056 / M5
Regulation status has entered into force: 04.11.2024
Regulation status: Allkirjastatud
Trahvihoiatusmäärus: majandusaasta aruanne esitamata
12.09.2024
Regulation number: Ä 10107056 / M4
Regulation status has entered into force: 12.09.2024
Regulation status: Allkirjastatud
Korduv aruandetrahvimäärus
02.05.2024
Regulation number: Ä 10107056 / M3
Regulation status has entered into force: 02.05.2024
Regulation status: Allkirjastatud
Aruandetrahvimäärus
24.01.2024
Regulation number: Ä 10107056 / M2
Regulation status has entered into force: 24.01.2024
Regulation status: Allkirjastatud
Trahvihoiatusmäärus: majandusaasta aruanne esitamata
26.09.2023
Regulation number: Ä 10107056 / M1
Regulation status has entered into force: 26.09.2023
Date of enforcement of order or additional period: 26.09.2023
Regulation status: Jõustunud
BIOINF OÜ
Decisions of the Consumer Disputes Committee as of 15.07.2026?
Consumer disputes MISSING
BIOINF OÜ
Court hearings as of 15.07.2026?
Court hearings MISSING
BIOINF OÜ
Rulings as of 15.07.2026?
Court settlemets MISSING
BIOINF OÜ
Notices and announcements as of 15.07.2026?
Announcements MISSING
Marketing
Business network
BIOINF OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Beneficiaries network
BIOINF OÜ
Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.